Compared with the primary tumor, in the metastasis group, the mesenchymal markers (CDH2, VIM, TWIST1, SNAI1, ZEB1) and ferroptosis drivers increased, and the epithelial marker CDH1 and ferroptosis suppressor decreased. This evidence concerns the gene CDH2 and neoplasm.